Drugs Made In America Acquisition Corp. Ordinary Shares
- DMAA
- NASDAQ
- Shell Companies
- SPAC/Blank Check Company
- Merger/Acquisition Target
$10.87
Today +0.09%Quote Oct 16, 2026, 08:00 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
+0.28%over the last month
Max drawdown −0.5%From 1-month high −0.2%3 months +1.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$263.9M
Quote Oct 16
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$10.78
0.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DMAAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Shell Companies
Employees
2
Founded
2024